MgSO 4 as a novel hypothermia infusion solution promotes ischemic stroke recovery through Ca 2+ regulation of neurovascular units
Theranostics · 2025
DOI: 10.7150/thno.104879 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Yang Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Magnesium Sulfate, Calcium, Ischemic Stroke, Hypothermia, Induced. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
The neuroprotection of acute ischemic stroke (AIS) patients to alleviate the reperfusion injury is a long-standing problem. Although the intra-arterial selective cooling saline infusion (IA-SCSI) is a promising technique to improve the outcome of AIS, the clinical results are not sufficiently satisfactory. Magnesium-containing solutions such as magnesium sulfate (MgSO4) can protect cells by modulating the intracellular Ca2+ content in damaged cells, suggesting that they could be hypothermia infusion solution. In this study, we hypothesized that MgSO4, as a novel hypothermia infusion solution (IA-SCMI), can promote AIS recovery.
Methods
First, IA-SCMI was performed in rats subjected to the middle cerebral artery occlusion. The effect of combined hypothermia and MgSO4 treatment on different neurovascular (NVU) cells after oxygen-glucose deprivation/reoxygenation (OGD/R) injury was examined.
Results
Compared with the IA-SCSI or IA-MgSO4 infusion alone, IA-SCMI offered the best protective effect by improving neurological defects, and alleviating brain integrity damage and CBF reduction. Meanwhile, in vitro results revealed that the combination of hypothermia and MgSO4 provided maximum protection to the NVU cells, and this protective effect was mainly achieved through the regulation of Ca2+ homeostasis in different cells.
Conclusion
MgSO4 may be a promising hypothermia infusion solution to facilitate the recovery of neurological function in AIS patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
- China-America Institute of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
- Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China.
- Department of Neurosurgery, Tianjin Huanhu Hospital, Tianjin, China.
- School of Materials Science and Engineering, Peking University; Beijing, China.
- Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
Zitieren
APA
Zhang, Y., Jiang, M., Wei, M., Wu, C., Huang, Y., Song, B., Xu, Y., Zhang, H., Shen, Y., Wu, D., Zheng, Y., Li, M., & Ji, X. (2025). MgSO 4 as a novel hypothermia infusion solution promotes ischemic stroke recovery through Ca 2+ regulation of neurovascular units. Theranostics. https://doi.org/10.7150/thno.104879
Vancouver
Zhang Y, Jiang M, Wei M, Wu C, Huang Y, Song B, et al. MgSO 4 as a novel hypothermia infusion solution promotes ischemic stroke recovery through Ca 2+ regulation of neurovascular units. Theranostics. 2025. doi:10.7150/thno.104879
BibTeX
@article{Zhang2025,
author = {Zhang, Yang and Jiang, Miaowen and Wei, Ming and Wu, Chuanjie and Huang, Yiming and Song, Baoying and Xu, Yi and Zhang, Hongkang and Shen, Yunong and Wu, Di and Zheng, Yufeng and Li, Ming and Ji, Xunming},
title = {MgSO 4 as a novel hypothermia infusion solution promotes ischemic stroke recovery through Ca 2+ regulation of neurovascular units},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.104879}
}
EUVIMED